Similar Items: Evaluation of Treatment Outcomes of Patients with Chronic Phase Chronic Myelogenous Leukemia (CML) to Imatinib: A Single Centre Experience 2010-2015 Period
- Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemia
- Imatinib resistance : the role of pharmacogenetic variability in a South African chronic myeloid leukemia cohort
- Genetic Analysis of Imatinib Resistance in CML: The Role of T315I and E255K
- Blood Pressure Alterations in CML Patients Treated with Imatinib vs. Nilotinib : A Clinical Insight
- Gastric cancer beyond chronic stress
- Histological and Biochemical Evaluation of the Kidney following Chronic Consumption of Hibiscus sabdariffa